100
Participants
Start Date
January 10, 2025
Primary Completion Date
September 23, 2027
Study Completion Date
December 23, 2027
The patient will receive two intravenous injections of the same gadoterate meglumine contrast agent.
Each patient will undergo two different field strength HR-VWIs with enhancement, and on each occasion the patient will be injected with contrast DOTAREM (gadoterate meglumine) .
RECRUITING
Shanghai Sixth People's Hospital, Shanghai,200023, Shanghai
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
OTHER